The pathological response to DNA damage does not contribute to p53-mediated tumour suppression

Nature

Volumn 443, Issue 7108, 2006, Pages 214-217

  Christophorou, M A ^a   Ringshausen, I ^a   Finch, A J ^a   Swigart, L Brown ^a   Evan, G I ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELLS; CHEMOTHERAPY; DNA; GENETIC ENGINEERING; IRRADIATION; MUTAGENESIS; PROTEINS; TOXICITY; TUMORS;

DNA DAMAGE; GENOTOXIC CARCINOGEN; METAZOANS; TUMOR SUPPRESSION;

ONCOLOGY;

CARCINOGEN; PROTEIN P19; PROTEIN P53;

APOPTOSIS; CHEMOTHERAPY; DNA; GENOTOXICITY; METAZOAN; ONTOGENY; PATHOLOGY; PROTEIN; TUMOR;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CELL CYCLE; DNA DAMAGE; GENOTOXICITY; IN VIVO STUDY; IRRADIATION; LYMPHOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RADIATION RESPONSE;

ANIMALIA; METAZOA; VERTEBRATA;

EID: 33748670457     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature05077     Document Type: Article

References (29)

1. Lane, D. P. p53, guardian of the genome. Nature 358, 15-16 (1992).
2. Gudkov, A. V. & Komarova, E. A. The role of p53 in determining sensitivity to radiotherapy. Nature Rev. Cancer 3, 117-129 (2003).
3. Christophorou, M. A. et al. Temporal dissection of p53 function in vitro and in vivo. Nature Genet. 37, 718-726 (2005).
4. Lain, S. & Lane, D. Improving cancer therapy by non-genotoxic activation of p53. Eur. J. Cancer 39, 1053-1060 (2003).
5. Jacks, T. et al. Tumor spectrum analysis in p53-mutant mice. Curr. Biol. 4, 1-7 (1994).
6. Donehower, L. A. et al. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356, 215-221 (1992).
7. Kemp, C. J., Wheldon, T. & Balmain, A. p53-deficient mice are extremely susceptible to radiation-induced tumorigenesis. Nature Genet. 8, 66-69 (1994).
8. Komarova, E. A. & Gudkov, A. V. Could p53 be a target for therapeutic suppression? Semin. Cancer Biol. 8, 389-400 (1998).
9. Gorgoulis, V. G. et al. Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature 434, 907-913 (2005).
10. Bartkova, J. et al. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 434, 864-870 (2005).
11. Prowse, K. R. & Greider, C. W. Developmental and tissue-specific regulation of mouse telomerase and telomere length. Proc. Natl Acad. Sci. USA 92, 4818-4822 (1995).
12. Kipling, D. & Cooke, H. J. Hypervariable ultra-long telomeres in mice. Nature 347, 400-402 (1990).
13. Wu, X. & Levine, A. J. p53 and E2F-1 cooperate to mediate apoptosis. Proc. Natl Acad. Sci. USA 91, 3602-3606 (1994).
14. Wagner, A. J., Kokontis, J. M. & Hay, N. Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21waf1/cip1. Genes Dev. 8, 2817-2830 (1994).
15. INK4a. Cell 88, 593-602 (1997).
16. Lowe, S. W., Cepero, E. & Evan, G. Intrinsic tumour suppression. Nature 432, 307-315 (2004).
17. Hermeking, H. & Eick, D. Mediation of c-Myc-induced apoptosis by p53. Science 265, 2091-2093 (1994).
18. Zindy, F. et al. Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. Genes Dev. 12, 2424-2433 (1998).
19. ARF links the tumour suppressor p53 to Ras. Nature 395, 125-126 (1998).
20. ARF tumor suppressor. Genes Dev. 12, 2434-2442 (1998).
21. ARF links the tumour suppressors RB and p53. Nature 395, 124-125 (1998).
22. Quelle, D. E., Zindy, F., Ashmun, R. A. & Sherr, C. J. Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell 83, 993-1000 (1995).
23. Mao, L. et al. A novel p16INK4A transcript. Cancer Res. 55, 2995-2997 (1995).
24. ARF. Cell 91, 649-659 (1997).
25. Zindy, F. et al. Arf tumor suppressor promoter monitors latent oncogenic signals in vivo. Proc. Natl Acad. Sci. USA 100, 15930-15935 (2003).
26. Sluss, H. K., Armata, H., Gallant, J. & Jones, S. N. Phosphorylation of serine 18 regulates distinct p53 functions in mice. Mol. Cell. Biol. 24, 976-984 (2004).
27. Liao, M. J., Yin, C., Barlow, C., Wynshaw-Boris, A. & van Dyke, T. Atm is dispensable for p53 apoptosis and tumor suppression triggered by cell cycle dysfunction. Mol. Cell. Biol. 19, 3095-3102 (1999).
28. Harms, K., Nozell, S. & Chen, X. The common and distinct target genes of the p53 family transcription factors. Cell. Mol. Life Sci. 61, 822-842 (2004).
29. Soengas, M. S. & Lowe, S. W. p53 and p73: seeing double? Nature Genet. 26, 391-392 (2000).